Vaxelis™ Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine 15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL Injection 0.5 mL

Name: DTaP, Polio, Hib, and Hepatitis B Vaccine
Brand: Vaxelis™

VAXELIS DTAP-IPV/HIB/HEPB, SDV0.5ML (10/CT)

McKesson #

1195617

Manufacturer #

63361024310

Brand

Vaxelis™

Manufacturer

Sanofi Pasteur

Country of Origin

Unknown

Application

DTaP, Polio, Hib, and Hepatitis B Vaccine

Buy American Act (BAA) Compliant

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Code

40619

Generic Drug Name

Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine

NDC Number

63361024310

Storage Requirements

Requires Refrigeration

Strength

15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL

Trade Agreement Act (TAA) Compliant

Yes

Type

Intramuscular

UNSPSC Code

51202101

User

Indicated for People 6 Weeks Through 4 Years of Age

Volume

0.5 mL

VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib)
VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday)
VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit